Literature DB >> 9783532

The cytokine response to bacille Calmette Guérin vaccination in South India.

S D Das1, P R Narayanan, C Kolappan, M J Colston.   

Abstract

SETTING: Evaluation of immune response after BCG vaccination in a population from South India where BCG vaccination was a failure.
OBJECTIVE: To study the cell-mediated immune responses (CMI) in vitro by assessing skin test conversion, lymphocyte proliferation and cytokine patterns before and after BCG vaccination in 20 Mantoux negative subjects, and to compare this with that of 20 naturally Mantoux positive subjects.
DESIGN: In vitro lymphocyte proliferation and cytokine responses to various mycobacterial antigens were studied in 12 subjects from each group. The cytokines interferon gamma (IFN-gamma), interleukin (IL)-4 and IL-10 were measured by both reverse transcriptase polymerase chain reaction (RT-PCR) and enzyme linked immunosorbent assay (ELISA).
RESULTS: All of those who were initially Mantoux negative but one subject converted to positivity following vaccination, confirming that BCG vaccination does cause skin test conversion. However, in vitro proliferative responses to phytohaemagglutinin (PHA), purified protein derivative (PPD) and Mycobacterium tuberculosis remained largely unaltered by vaccination. The production of IFN-gamma was significantly higher in PPD-positive individuals compared to the PPD-negative group, and BCG vaccination of the latter did not change the levels of IFN-gamma, IL-4 or IL-10.
CONCLUSIONS: The finding that PPD-negative individuals did not produce IFN-gamma even following vaccination and skin test conversion suggests that BCG had little effect in driving the immune response towards a protective Th1 type.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783532

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  5 in total

1.  Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination.

Authors:  D Elias; D Wolday; H Akuffo; B Petros; U Bronner; S Britton
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Association of interleukin-10 cytokine expression status with HLA non-DRB1*02 and Mycobacterium bovis BCG scar-negative status in south Indian pulmonary tuberculosis patients.

Authors:  V Dheenadhayalan; S Shanmugalakshmi; S Vani; P Muthuveeralakshmi; G Arivarignan; A D Nageswari; R M Pitchappan
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Cell-mediated immune responses of healthy laboratory volunteers to sonicate antigens prepared from the most prevalent strains of Mycobacterium tuberculosis from South India harboring a single copy of IS6110.

Authors:  Priya Rajavelu; Sulochana D Das
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

4.  Modulation of humoral immune response to oral BCG vaccination by Mycobacterium bovis BCG Moreau Rio de Janeiro (RDJ) in healthy adults.

Authors:  Renata Monteiro-Maia; Maria B Ortigão-de-Sampaio; Rosa T Pinho; Luiz R R Castello-Branco
Journal:  J Immune Based Ther Vaccines       Date:  2006-09-06

Review 5.  Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections.

Authors:  Davit Orujyan; William Narinyan; Subhapradha Rangarajan; Patrida Rangchaikul; Chaya Prasad; Beatrice Saviola; Vishwanath Venketaraman
Journal:  Vaccines (Basel)       Date:  2022-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.